Recognizing several longstanding impediments to telepsychology's and telemedicine's adoption, agencies within the U.S. government quickly pivoted on multiple policies, unleashing telepsychology's and telemedicine's ability to play an important role in delivery or care during the COVID‐19 pandemic. On March 16, 2020, the “in‐person” requirement set forth by the Ryan Haight Act was suspended indefinitely, allowing practitioners to prescribe Schedule II–V controlled substances as long as the exam occurred using a two‐way, audio‐visual, real‐time communication system (U.S. Drug Enforcement Administration Diversion Control Division, 2020). Additionally, Medicare and Medicaid temporarily increased access to care by allowing psychologists, licensed clinical social workers, physicians, and nurse practitioners to be reimbursed for telepsychology and telemedicine visits with patients across the country, including within patients' homes, and at the same rates as in‐person visits (U.S. Centers for Medicare & Medicaid Services, 2020). The American Psychological Association advocated for reimbursement parity for telepsychology sessions conducted by phone only (DeAngelis, 2020). The Department of Health and Human Services' Office for Civil Rights (OCR) also temporarily waived the HIPAA Security and Privacy Rule requirements that had previously prevented the use of common communications apps such as FaceTime and Skype (U.S. Department of Health and Human Services' Office for Civil Rights, 2020a, 2020b). These important changes in response to the global emergency highlighted the numerous, long‐standing obstacles to telepsychology and telemedicine adoption that have resulted from policies and regulations within the United States.